Terms: = Kidney tumors AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Prognosis
21 results:
1. Factors affecting survival and prognosis in surgically treated patients with spinal metastases arising from renal cell carcinoma.
Lei M; Miao J
BMC Urol; 2023 Jul; 23(1):118. PubMed ID: 37443069
[TBL] [Abstract] [Full Text] [Related]
2. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy.
Chen X; Zhang T; Zhan X; Zang X; Zhai X; Wan Z; Ge M; Tan M; Gu J; Xu D
Genet Res (Camb); 2023; 2023():2355891. PubMed ID: 36741922
[TBL] [Abstract] [Full Text] [Related]
4. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract] [Full Text] [Related]
5. Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.
Tamukong PK; Kuhlmann P; You S; Su S; Wang Y; Yoon S; Gong J; Figlin RA; Janes JL; Freedland SJ; Halabi S; Small EJ; Rini BI; Kim HL
Urol Oncol; 2022 Nov; 40(11):495.e1-495.e10. PubMed ID: 35973929
[TBL] [Abstract] [Full Text] [Related]
6. Construction of circRNA-based ceRNA network and its prognosis-associated subnet of clear cell renal cell carcinoma.
Zhang Y; Zhang Y; Feng Y; Zhang N; Chen S; Gu C; Hu L; Sheng J; Xu B; Feng N
Cancer Med; 2021 Nov; 10(22):8210-8221. PubMed ID: 34569727
[TBL] [Abstract] [Full Text] [Related]
7. Low-Grade Oncocytic Tumor of kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics.
Kravtsov O; Gupta S; Cheville JC; Sukov WR; Rowsey R; Herrera-Hernandez LP; Lohse CM; Knudson R; Leibovich BC; Jimenez RE
Hum Pathol; 2021 Aug; 114():9-18. PubMed ID: 33961838
[TBL] [Abstract] [Full Text] [Related]
8. The significance of serum levels of soluble interleukin-2 receptor in patients undergoing maintenance hemodialysis.
Chen X; Li Y; Ding X; Zou J; Shen B; Liu Z; Lv W; Cao X; Xiang F
Ren Fail; 2020 Nov; 42(1):419-427. PubMed ID: 32401100
[No Abstract] [Full Text] [Related]
9. ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma.
Xu T; Ruan H; Gao S; Liu J; Liu Y; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Shi J; Liang H; Yang H; Chen K; Zhang X
Aging (Albany NY); 2020 Jan; 12(2):1808-1827. PubMed ID: 32003757
[TBL] [Abstract] [Full Text] [Related]
10. Screening, identification and validation of ccnd1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.
Yang JF; Shi SN; Xu WH; Qiu YH; Zheng JZ; Yu K; Song XY; Li F; Wang Y; Wang R; Qu YY; Zhang HL; Zhou XQ
Aging (Albany NY); 2019 Dec; 11(24):12057-12079. PubMed ID: 31850854
[TBL] [Abstract] [Full Text] [Related]
11. Serious clinical events in HIV-positive persons with chronic kidney disease.
Ryom L; Lundgren JD; Law M; Kirk O; El-Sadr W; Bonnet F; Weber R; Fontas E; Monforte AD; Phillips A; Reiss P; de Wit S; Hatleberg CI; Sabin C; Mocroft A;
AIDS; 2019 Nov; 33(14):2173-2188. PubMed ID: 31385862
[TBL] [Abstract] [Full Text] [Related]
12. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
[TBL] [Abstract] [Full Text] [Related]
13. Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.
Wang QS; Li F; Liao ZQ; Li K; Yang XL; Lin YY; Zhao YL; Weng SY; Xia Y; Ye Y; Li SH; Wang CY; Lin Y
Cancer Med; 2019 Aug; 8(9):4100-4109. PubMed ID: 31183974
[TBL] [Abstract] [Full Text] [Related]
14. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
[TBL] [Abstract] [Full Text] [Related]
15. High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma.
Chang Y; Zhou L; Xu L; Fu Q; Yang Y; Lin Z; Xu J
Urol Oncol; 2017 Dec; 35(12):675.e17-675.e24. PubMed ID: 28918166
[TBL] [Abstract] [Full Text] [Related]
16. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell Carcinoma: A PRISMA-compliant Systematic Review and Meta-Analysis.
Fan Y; Li H; Ma X; Gao Y; Chen L; Li X; Bao X; Du Q; Zhang Y; Zhang X
Medicine (Baltimore); 2015 Sep; 94(38):e1646. PubMed ID: 26402839
[TBL] [Abstract] [Full Text] [Related]
18. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
[TBL] [Abstract] [Full Text] [Related]
19. [Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer].
Waalkes S; Eggers H; Rustemeier J; Wegener G; Jentzmik F; Schrader M; Hofmann R; Kuczyk MA; Schrader AJ;
Urologe A; 2011 Sep; 50(9):1118-24. PubMed ID: 21720831
[TBL] [Abstract] [Full Text] [Related]
20. Amplification and expression of EGFR and ERBB2 in Wilms tumor.
Vasei M; Modjtahedi H; Ale-Booyeh O; Mosallaei A; Kajbafzadeh AM; Shahriari M; Ghaderi AA; Soleymanpour H; Kosari F; Moch H; Sauter G
Cancer Genet Cytogenet; 2009 Oct; 194(2):88-95. PubMed ID: 19781441
[TBL] [Abstract] [Full Text] [Related]
[Next]
